These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


297 related items for PubMed ID: 9349569

  • 1. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM, Dávila-García MI, Ulrich YM, Kellar KJ.
    J Neurochem; 1997 Nov; 69(5):2216-9. PubMed ID: 9349569
    [Abstract] [Full Text] [Related]

  • 2. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W, Gillberg PG, Nordberg A.
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [Abstract] [Full Text] [Related]

  • 3. Chronic nicotine administration does not increase nicotinic receptors labeled by [125I]epibatidine in adrenal gland, superior cervical ganglia, pineal or retina.
    Dávila-García MI, Musachio JL, Kellar KJ.
    J Neurochem; 2003 Jun; 85(5):1237-46. PubMed ID: 12753083
    [Abstract] [Full Text] [Related]

  • 4. A comparison of multiple injections versus continuous infusion of nicotine for producing up-regulation of neuronal [3H]-epibatidine binding sites.
    Ulrich YM, Hargreaves KM, Flores CM.
    Neuropharmacology; 1997 Aug; 36(8):1119-25. PubMed ID: 9294978
    [Abstract] [Full Text] [Related]

  • 5. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
    Khan IM, Yaksh TL, Taylor P.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
    [Abstract] [Full Text] [Related]

  • 6. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex.
    Zhang X, Gong ZH, Fasth KJ, Långström B, Nordberg A.
    Neurochem Int; 1998 Jul; 32(5-6):435-41. PubMed ID: 9676742
    [Abstract] [Full Text] [Related]

  • 7. Epibatidine binding sites and activity in the spinal cord.
    Khan IM, Yaksh TL, Taylor P.
    Brain Res; 1997 Apr 11; 753(2):269-82. PubMed ID: 9125412
    [Abstract] [Full Text] [Related]

  • 8. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain.
    Miao H, Liu C, Bishop K, Gong ZH, Nordberg A, Zhang X.
    J Neurochem; 1998 Feb 11; 70(2):752-62. PubMed ID: 9453571
    [Abstract] [Full Text] [Related]

  • 9. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
    Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, Le Novère N.
    J Comp Neurol; 2003 Jun 16; 461(1):49-60. PubMed ID: 12722104
    [Abstract] [Full Text] [Related]

  • 10. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ, Whiteaker P, Collins AC.
    Mol Pharmacol; 2006 Sep 16; 70(3):947-59. PubMed ID: 16728647
    [Abstract] [Full Text] [Related]

  • 11. Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine.
    Dávila-García MI, Houghtling RA, Qasba SS, Kellar KJ.
    Brain Res Mol Brain Res; 1999 Mar 20; 66(1-2):14-23. PubMed ID: 10095073
    [Abstract] [Full Text] [Related]

  • 12. Time and brain region specific up-regulation of low affinity neuronal nicotinic receptors during chronic nicotine administration in mice.
    Nuutinen S, Ahtee L, Tuominen RK.
    Eur J Pharmacol; 2005 May 16; 515(1-3):83-9. PubMed ID: 15894304
    [Abstract] [Full Text] [Related]

  • 13. Regional distribution of nicotinic receptors during prenatal development of human brain and spinal cord.
    Hellström-Lindahl E, Gorbounova O, Seiger A, Mousavi M, Nordberg A.
    Brain Res Dev Brain Res; 1998 Jun 15; 108(1-2):147-60. PubMed ID: 9693793
    [Abstract] [Full Text] [Related]

  • 14. [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study.
    Perry DC, Kellar KJ.
    J Pharmacol Exp Ther; 1995 Nov 15; 275(2):1030-4. PubMed ID: 7473129
    [Abstract] [Full Text] [Related]

  • 15. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec 15; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 16. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ, Meinerz NM, Drago J, Collins AC.
    Neuropharmacology; 2007 Sep 15; 53(3):390-405. PubMed ID: 17631923
    [Abstract] [Full Text] [Related]

  • 17. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec 15; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 18. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE, Loetz EC, Marks MJ.
    Pharmacol Biochem Behav; 2015 Mar 15; 130():1-8. PubMed ID: 25560939
    [Abstract] [Full Text] [Related]

  • 19. Autoradiographic comparison of [3H](-)nicotine, [3H]cytisine and [3H]epibatidine binding in relation to vesicular acetylcholine transport sites in the temporal cortex in Alzheimer's disease.
    Sihver W, Gillberg PG, Svensson AL, Nordberg A.
    Neuroscience; 1999 Mar 15; 94(3):685-96. PubMed ID: 10579560
    [Abstract] [Full Text] [Related]

  • 20. Differential regulation of nicotinic receptor-mediated neurotransmitter release following chronic (-)-nicotine administration.
    Jacobs I, Anderson DJ, Surowy CS, Puttfarcken PS.
    Neuropharmacology; 2002 Oct 15; 43(5):847-56. PubMed ID: 12384170
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.